Aim: To evaluate whether the newly-synthesized positron emission tomography (PET) tracer, [ In the dynamic and static micro-PET images, increased radioactivity was found in the area of the right HT in the model rats where infused with β-amyloid (1-40). No distinct difference of radioactivity was found between the right and left HT areas in the control rats. The ADV( HT ) was approximately 14.6% in the AD model rats and approximately 4 times greater than that of the control rats (3.9%). Conclusion: To our knowledge, this study is the first to evaluate a small molecular PET probe for the β-amyloid deposits in vivo using micro-PET imaging in an AD-injected rat model. The suitable biological characters showed that the tracer had potential to be developed as a probe for detecting β-amyloid plaques in AD.
Introduction
During the rapid development of in vivo amyloid imaging agents for the early diagnosis of Alzheimer's disease (AD) [1] , some efforts were made to use high-resolution micro-positron emission tomography (PET) imaging in the transgenic mouse model of central nervous system amyloid deposition to further study Pittsburgh compound-B ([ 11 C]PIB), a PET tracer that has been shown to be increased in amyloidaggregate areas of the AD brain. However, some types of transgenic mice, including PS1/APP and Tg2576, showed no significant retention of PIB in these models, even at 12 or 22 months of age when amyloid deposition exceeded that distinctly seen in AD [2, 3] . Klunk et al studied the reason and found that PS1/APP mouse brain tissues contained less than 1 high-affinity PIB binding site per 1000 molecules of β-amyloid, whereas the AD brain contained >500 PIB binding sites per 1000 molecules of β-amyloid. The tiny amount (nmol/L) of the PET tracer, the small amount of high-binding sites, and the low detection efficiency (2%) of the micro-PET might be the main reasons for the absence of tracer retention in the transgenic mice. Cai et al reported their initial efforts to evaluate [ 11 C] PIB for imaging brains of Tg2576 mice. They also did not find any specific binding in the cerebrum, only non-specific binding comparable to that in the cerebellum. Interestingly, when they used much older transgenic Tg2576 mice (28 months' old), they observed a ratio of radioactivity in the cerebrum to that in the cerebellum of approximately 1.8 at 25 min after an injection of [ 11 C]PIB [4] . Their case was successful in exhibiting micro-PET imaging of β-amyloid deposits in rodent brains.
Shimadzu et al found a hot spot at 180 min after the intravenous administration of [ and a buffer only on the opposite site had been injected 6 d before with an autoradiographic image [5] . Previous studies showed the compound O-FEt-PIB had a high affinity to β-amyloid and high lipophilicity [6] [7] [8] . In the present study, we first observed the increased uptake of [ 18 F]O-FEt-PIB in the right hemicerebrum of an injected AD rat where β-amyloid (1-40) and a saline only on the opposite site were injected using micro-PET imaging.
Materials and methods
General equipment and reagents HPLC was carried out on a Dionex system equipped with a P680 pump, a PDA-100 photodiode array detector (Dionex Corporation, Sunnyvale, CA, USA), and a NaI (Tl) scintillation detector (Bioscan, Washington, DC, USA). The columns used for the identification and purification were LiChrosorb C18 (5 µm, 300 mm×3. 9 mm and 10 µm, 300 mm×7.8 mm (Waters, Milford, MA, USA), respectively;. The column effluent passed through an UV (365 nm) detector and scintillation radioactivity detector in series. The HPLC solvents consisted of CH 3 OH (solvent A) and 0.1% CF 3 COOH/H 2 O (solvent B). HPLC gradient was set as follows: 0-1 min 70% B, 1-25 min 20%, 25-40 min 20%. The flow rates of purification and analysis were 3 mL/min (condition 1, with column 300 mm×7.8mm) and 1 mL/min (condition 2, with column 300 mm×3.9 mm), respectively.
Radio-TLC (Thin Layer Chromatography, Merck, Darmstadt, Germany) analyses were performed using silica gel 60 GF-254 plates (Merck, Darmstadt, Germany) on a Bioscan system AR-2000 (Bioscan, Washington, DC, USA) with Winscan software version 3.09 (Bioscan, Washington, DC, USA). The radioactivity measurements were done using an automatic gamma counter (3 inch NaI[Tl] well crystal; Jiading, Shanghai, China) coupled to a multichannel analyzer (SN682B; Jiading, Shanghai, China) [9] . Synthetic human β-amyloid protein (1-40) was purchased from Sigma-Aldrich Synthesis (Steinheim, Germany). Other commercial reagents were purchased from Shanghai Reagent (Shanghai, China), and used without further purification unless otherwise specified.
Synthesis of [ 18 F]O-FEt-PIB
The cold reference compound O-FEt-PIB was synthesized as described in our previous work [6] . The radiosynthesis procedure of [ 18 F]O-FEt-PIB and its primary characters were described in Zheng et al [10] . Animal preparation The model and control rats were prepared as described in Wang et al and Nitta et al [11, 12] . Male Sprague-Dawley rats, weighing 200-220 g at the beginning of the experiment, were housed individually in a room maintained at 23 °C with a 12 h light-dark cycle for the duration of the experiment. In total, 6 µg aggregated β-amyloid (1-40) with 6 µL dissolved in sterile, distilled water (prepared by incubating soluble β-amyloid at 37 °C for at least 7 d) was stereotaxically injected into the hippocampus (-3.0 mm AP, -2.2 mm ML, and -3 mm DV) in rats under barbital anesthesia using a microsyringe. One week was allowed for re-covery from the surgery. The control rats were infused with the same quantity of sterile, distilled water. One month after the surgery, 3 randomly-selected model rats were killed by decapitation after heart perfusion. The brains were rapidly removed and placed on ice. The brain tissues were fixed for immunohistochemical evaluation. Other normal and postoperative rats were used for micro-PET imaging or other in vivo/in vitro conventional experiments. All of the experiments complied with the current laws of China and met ethical approval. F]O-FEt-PIB in 100 µL saline through the lateral tail vein. The animals were killed by cardiac excision following cardiac puncture to obtain arterial blood samples and decapitation to obtain brains and crania at 2, 30, 60, and 120 min postinjection. The brains were rapidly excised and divided into cerebellum, cortex, and cerebrum. All of the samples were weighed and counted, and the counts were corrected for decay. The radioactivity of tissues was determined as the percentage of injected dose per gram of tissue normalized to body weight (in kg) or (%ID-kg)/g.
High-resolution micro-PET scanning PET imaging was performed using a micro-PET R4 rodent model scanner (CTI Concorde Microsystems, Knoxville, TN, USA), which was equipped with micro-PET manager for data acquisition in list mode and ASIPro for preparing sinograms and image reconstruction [13] . The scanner had a computer-controlled bed and 10.8 cm transaxial and 7.8 cm axial field of view (FOV) with an image resolution of <1.8 mm. [ 18 F]FDG (0.5 mCi each rat) was prepared with a specific activity of 500 Ci/mmol, which was provided by the Department of Nuclear Medicine, Zhejiang University School of Medicine (Hangzhou, China).
A total of 4 AD and 3 control male Sprague-Dawley rats were imaged by micro-PET using [ ]O-FEt-PIB was injected via the tail vein while the rat was placed at the center of the FOV (field of view) of the scanner and scanned just after the injection. The dynamic PET data were acquired on an AD rat for 40 min (10 s×6 frames, 30 s×6 frames, 60 s×5 frames, 300 s×4 frames, and 600 s×1 frame). The other animals were anesthetized first, receiving an injection of PET tracers, and were then placed at the center of the FOV of the micro-PET R4 scanner and underwent a 15 min static scan. Three AD rats were scanned for 15 min at 5 min postinjection. The control rats (n=3) were scanned based on the same methods as the model rats.
Images were reconstructed by a maximum posteriori probability algorithm. Corrections for dead time, random scattering, and attenuation were performed for all scans.
PET data analysis Regions of interest (ROI) were manually placed over the cerebellum, hemicerebrum, and cortex. A 3-D digital map of the rat was used for the identification of the anatomical structures [14] and the [ -ion was generated in the metabolism. This result was confirmed by the dynamic scan with micro-PET. Even at 40 min, there was no distinct increased radioactivity in the crania. However, the clearance rate of radioactivity from the brain tissues was slow. The 2-60 min brain radioactivity ratio was approximately 6, and this characteristic was not as good as that of PIB (2-30 min ratio, 12 [15] ). Considering the disadvantage of AD transgenic mouse models in micro-PET imaging, we prepared a commonly-used AD rat model, in which the amyloid protein (1-40) was administered to the rats in vivo to evaluate the AD PET tracer using micro-PET. This model has successfully evaluated the effects of a Chinese traditional drug, huperzine A [11] . To understand the position and pervasion of the injected amyloid-β (1-40), we performed an immunohistochemical evaluation. The results are shown in Figure 2 . Figure 2 shows the amyloid deposits in the right hippocampus. The deposits were diffused in the area of hippocampus, and a spot on it was caused by an air bubble ( Figure 2B ); there were no detected amyloid deposits in the left hippocampus (Figure 2A ). Figure 3 shows the time-activity curves (TAC) of the regional distribution of radioactivity in the rat brain after the injection of the tracer. The maximum radioactivity obtained from the data was defined as 100, and other values were calculated as a ratio of the maximum radioactivity. This result correlated with the conventional method ( Figure 1 ) and showed a quick brain uptake and slow washout.
Results

Brain distribution of [
Micro-PET results
The distribution of [ 18 F]O-FEt-PIB in the rat brains in vivo using micro-PET is also shown (Figures 4-7) , and the results are interesting. Figure 4 shows the representative summed image of the dynamic scanning, which contained 23 frames of images. The fusional picture exhibited an unsymmetrical distribution of the radiotracer in the 2 hemicerebrums. The distribution of [ 18 F]O-FEt-PIB in the single images, which were neither from early time (recorded at 0-5 min) or at late time (recorded at 30-40 min) showed no distinct difference in 2 hemicerebrums because the images were blurry or radioactivity was low (Figure 3 ). Figure 5 shows the increased aggregates of radioactivity in the right hemicerebrum in the AD model rats infused with 6 µg β-amyloid (1-40). Figure 5 shows a similar uptake of the radio tracer between the 2 hemicerebrums. This result indicated that the surgery could not induce an increased aggregate of the tracer after recovery. Figure 6 shows the adjacent transverse slices (each 0.12 mm thick), which confirmed the special distribution of the tracer in the special regions (the areas adjacent to the hippocampus) of the rat brains. ROI were defined on the 3-D digital map, and the mean activities were auto-given by the microPET ASIPro (Figure 7 ). The ADV( HT ) was approximately 14.6% in the AD model rats, which was approximately 4 times great than that of the control rats (3.9%). The ADV in the cortex was 2.9% in the model rats compared to 5.6% in the control rats.
Discussion
Animal models of AD play an important role in understanding the pathology of the disease, the diagnosis, or therapeutic drugs. Although no current model has developed the full pathological spectrum of the disease, the transgenic rodent model was an ideal choice. However, recent studies have shown that although a large amount of amyloid plaques exist in the transgenic mouse brain, not enough high-binding sites could "capture" enough amounts of the [ 11 C]PIB to form an aimed images using micro-PET imaging. Nitta et al and Wang et al have reported an injected rat model, which shows that injected β-amyloid could impair memory and elicit a degree of Alzheimer-type neurodegeneration. In the present study, we tried to apply this rat model for the in vivo imaging of β-amyloid deposits in the right hippocampus with micro-PET using a new synthesized PET tracer, [ In the present study, the brain, blood, and bone uptake and micro-PET imaging demonstrated excellent brain uptake of radioactivity in the rat brains. To our knowledge, this study is the first to show an increased aggregate of a small molecu- lar PET probe for the aggregates of β-amyloid using in vivo micro-PET imaging with an AD-injected rat model. Further studies about new tracers and new AD rodent models are currently being undertaken in our laboratory.
